Roche in $1 billion RNAi deal with Alnylam Pharmaceuticals
July 09 2007
Swiss drugmaker Roche said it has entered a deal worth up to $1 billion with Alnylam Pharmaceuticals to gain access ...
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
The e-mail address(es) that you supply to use this service will only be used to send the requested article.